Incomplete systemic lupus erythematosus - what remains after application of ACR and SLICC criteria?
Incomplete systemic lupus erythematosus (iSLE) is an acknowledged condition of patients with clinical signs of lupus who do not fulfill classification criteria for SLE. Some iSLE patients have persistent mild disease, but others have serious organ involvement, and up to 55% progress to established SLE. Research on this subject could reveal predictive or diagnostic biomarkers for SLE. Ideally, it would become possible to discriminate those patients with critical organ involvement or a high risk for progression to SLE. This "high risk" group might benefit from early treatment, which would preferably be confirmed in randomized controlled trials. However, this requires agreement on a definition of iSLE. The Systemic Lupus International Collaborating Clinics (SLICC) classification criteria was composed in order to diagnose SLE earlier. This review outlines the clinical characteristics of iSLE after introduction of SLICC criteria, and furthermore proposes a definition of iSLE, with the aim of discriminating the "high risk" group. This article is protected by copyright. All rights reserved.